Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV.

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries worldwide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Cilag AG is an international operating company integrated in the Janssen Pharmaceutical Companies of Johnson & Johnson that provides its customers with highest quality active pharmaceutical ingredients and pharmaceutical products worldwide. To achieve this they comply with worldwide Quality, Health, Safety and Environmental standards. These standards are basically ensured by their more than 1000 well trained and developed, conscientious and highly motivated employees, who are their most valuable capital.

LG H&H Co., Ltd. engages in the production and sale of household goods and cosmetic products. It operates through following divisions Beauty, Health and Refreshment businesses. The Beauty business division provides anti-aging cosmetic products. The Health division markets healthcare, skincare and household products. The Refreshment division provides soda, juice, energy drinks and other beverages. The company was founded on April 3, 2001 and is headquartered in Seoul, South Korea.

Xi'an Xintong Pharmaceutical Research Co., Ltd. engages in the research and development of medicines. Its products include pradefovir tablets, injection for advanced primary liver cancer, tablets for hepatitis B, and Cerebyx-Fosphenytoin sodium injection. The company was founded by Deng Ke Zhang on May 30, 2000 and is headquartered in Xi’an, China.

Beijing Harmony Health Medical Diagnostics Co., Ltd. is a Chinese private company located in Beijing. The firm provides medical laboratory services. It was founded in 2010.

Ranbaxy, Inc. manufactures drugs and pharmaceutical products. It manufactures generic and over the counter drugs. It offers include anti-infective, analgesics, expectorants and treatments for gastrointestinal, cardiovascular, and central nervous system disorders. The company is headquartered in Princeton, NJ.

Wockhardt Ltd. is a Global pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with more than half of its revenue coming from Europe. In 2011–2012 its UK and USA sales alone were US$475 million. It has market presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. The Company has a market capitalisation of over ₹211 billion (US$3.1 billion) and an annual turnover of ₹36 billion (US$520 million). It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 8,600 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group.

Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products. Their pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, new drug discovery (NDD), novel drug delivery systems (NDDS) and contract research and manufacturing services (CRAMS). They are globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors.

Bioprojet SCR is a French private company located in Paris, with subsidiaries in France, that provides research and development services.

Hebei Tiancheng Pharmaceutical Co., Ltd., established on 1998-09-28, Business scope includes production:tablet(Hormone),Granules,hard capsule,large volume injection(Contains polypropylene plastic bottle,Co-extruded film infusion bag,Polypropylene blend infusion bag,Stand-up Polypropylene Infusion Bag,External barrier bag three-layer co-extruded infusion bag,Polypropylene infusion bottle with outer barrier bag,Outer barrier bag five-layer co-extruded infusion bag),douche,API(Fasudil Hydrochloride),Powder,Extract(Ginkgo biloba extract)(Jinguang Street, Cangzhou Economic and Technological Development Zone18Production);small volume injection(Hormone,Polyethylene ampoule,Polypropylene ampoules,Polypropylene ampoules in outer barrier bag,LDPE ampoules in outer barrier bag),powder injection,medical supplements(Calcium Gluconate),API(sodium gluconate),Sterile API(Creatine Phosphate Sodium),Pharmaceutical Intermediates(5-Amino-1-Methyl-1H-Benzimidazole-2-ethyl butyrate)(Xingye Road, Cangzhou Economic and Technological Development Zone51Production);API(peramivir trihydrate,Calcium Ketoleucine,calcium ketophenylalanine,Calcium Ketovaline,Calcium racemic ketone isoleucine,Calcium racemic hydroxymethionine,sodium gluconate,calcium gluconate,Metformin Hydrochloride,Lidocaine Hydrochloride,Moxifloxacin hydrochloride,Levofloxacin),medical supplements(Calcium Gluconate),Sterile API(Creatine Phosphate Sodium),Feed additives(tricalcium phosphate),industrial salt(Sodium chloride),Pharmaceutical Intermediates(5-Amino-1-Methyl-1H-Benzimidazole-2-ethyl butyrate,1H-pyrazole-1-Formamidine hydrochloride,Moxifloxacin side chain,gaticyclate,Tetrafluorobenzoyl chloride,2-Ethylbutyraldehyde,barium bromide,Creatine Monohydrate),catalyst(Palladium Bismuth Carbon Catalyst)(Production on the east side of Jingsi Road, West District, Cangzhou Lingang Development Zone);Production,Sales:disinfectant(Free of Hazardous Chemicals);Acquisition of the company's production of Chinese medicinal materials;Import and export,Technology Import and Export;Realtor,Equipment Leasing;Pharmaceutical technology development,technology transfer,technical consulting,Technical Services;Heat supply service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments;General operating items,Can carry out business activities independently according to law).**

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Sun Pharmaceutical Industries Ltd., is an American company located in Hawthorne, NY. The firm manufactures and sells generic pharmaceutical products.

Qingdao Zhongren Pharmaceutical Co., Ltd., established on 2013-12-13, Business scope includes medical technology research and development and promotion services;Manufacture of daily disinfectant detergent(For mixing or dispensing only),Sales(None of the above products contain restricted or prohibited products such as hazardous chemicals,Freezing,refrigeration,Refrigeration,Hazardous Chemical Storage).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Shanghai New Asiatic Pharmaceuticals Co., Ltd. (doing business as New Asiatic Pharmaceuticals Co. Ltd.), a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., is a company headquartered in Shanghai, China, that manufactures and distributes pharmaceutical prodcuts. On September 20, 2011 Shanghai Pharmaceuticals Holding Co., Ltd. acquired Shanghai New Asiatic Pharmaceuticals Co., Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd.

Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.